T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis
Annals of Rheumatic Diseases May 25, 2019
Liu X, et al. - Researchers focused on the features of variations in T cell receptor (TCR) diversity as well as their clinical value in cases with systemic lupus erythematosus (SLE) (n=877), rheumatoid arthritis (RA)(n=206), and healthy controls (HC, n=439). Findings revealed that variable (V), joining (J) and V-J pairing differed significantly between the SLE or RA and HC groups, and these differences enabled perfectly accurate discrimination between the three groups. They identified 198 SLE-associated and 53 RA-associated TCRs. In SLE and RA, common characteristics and high similarity were displayed by disease-associated clones. Compared to RA, SLE showed higher TCR heterogeneity with several organ specific properties. Findings revealed the link between clonal expansion and the concentration of disease-associated clones with disease severity. Both diseases were enriched with pathogen-related TCRs. Potential of these features of the TCR repertoire, especially the disease-associated clones, to serve as biomarkers was suggested in this study.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries